Clinical Trials Sponsored by Innovative Institute

Total 75767 results

Innovative Medical

Completed

Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

Cataract

United States
Innovative Medical

Completed

Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

Glaucoma

United States
Innovative Medical

Completed

Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost

Glaucoma

United States
Instituto Palacios
eCareYou Innovation

Completed

Pilot Study for the Urinary Incontinence Treatment

Urinary Incontinence

Spain
Innovative Diagnostics Inc

Terminated

Rapid Point-of-Care Salivary Diagnostic for Periodontal Health

Gingivitis | Periodontal Disease

United States
Innovative Implant Solutions

Unknown

Evaluation of the Safety and Efficacy of Using ImplantLock Device - Dental Implant Accessory

Dental Implantation

Israel
Lawson Health Research Institute
Canada Foundation for Innovation; Ontario Innovative Trust; Ontario Research...

Completed

Coronary Stenting and Coronary Bypass Grafting at the Same Time in a Specialty Built Operating Room

Coronary Artery Disease

Canada
Innovative Molecules GmbH

Recruiting

Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of IM-250 in Healthy Volunteers

Herpes Simplex Virus

Germany
Memic Innovative Surgery

Recruiting

Clinical Assessment - HominisTM Surgical System

Hysterectomy

Belgium, Israel
Innovative Surgical Designs

Suspended

Pedicle Osteotomy for Stenosis Trial (POST)

Lumbar Spinal Stenosis | Spondylolisthesis, Grade 1 | Neurogenic Claudication

United States
Innovative Therapies, Inc.

Unknown

Efficacy of Quantum NPWT With Simultaneous Irrigation on Reduction of Wound Volume in Stage III/IV Pressure Ulcers.

Pressure Ulcers

United States
The Pelvic Floor Institute
Cystosure; Innovative Research Inc.

Unknown

Bladder Morphology Using 2 Different Catheter Designs

Urologic Diseases | Urinary Incontinence | Urinary Tract Infections | Pelvic Floor Disorders | Catheter-Related Infections | Catheter; Infection (Indwelling Catheter) | Urologic Injuries | Bladder Infection | Mucosal Inflammation | Mucosal Infection | Bladder Injury | Catheter Complications

United States
French Innovative Leukemia Organisation

Unknown

GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Lymphoma
French Innovative Leukemia Organisation

Unknown

GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma

Lymphoma
QualiMed Innovative Medizinprodukte GmbH

Recruiting

A PROSPECTIVE, MULTI-CENTER, SINGLE-ARM, POST MARKET OBSERVATIONAL STUDY TO EVALUATE THE SAFETY AND CLINICAL PERFORMANCE OF THE ARCHIMEDES BIODEGRADABLE BILIARY AND PANCREATIC STENT (AM GI Registry)

Obstructed Biliary and Pancreatic Duct

Spain, Israel, Finland, Italy, Slovenia, Germany
French Innovative Leukemia Organisation

Terminated

Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLL (BOMP)

B-cell Chronic Lymphocytic Leukemia (B-CLL)

France
French Innovative Leukemia Organisation

Terminated

Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma

Lymphoma

France
French Innovative Leukemia Organisation

Completed

Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP

Leukemia

France
Oculus Innovative Sciences, Inc.

Unknown

A Substantial Equivalence Study of RD04723 and Predicate Device

Hypertrophic Scar | Keloid Scar

United States
French Innovative Leukemia Organisation

Completed

Phase III Study Treatment of CLL B and C

Leukemia, Lymphocytic, Chronic
French Innovative Leukemia Organisation

Completed

Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage III

Leukemia, Lymphocytic, Acute

France
French Innovative Leukemia Organisation

Completed

Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

Acute Myeloid Leukemia

France
Texas Back Institute
CERSR; Innovative Spinal Technologies, Inc.

Unknown

Large Array EMG Discriminability in Discogenic Low Back Pain

Discogenic Pain

United States
French Innovative Leukemia Organisation

Recruiting

Prognostic Analyses on a Validation Series of Patients With Waldenström's Disease (SérieProWM)

Waldenstrom's Disease | Prognostic Index

France
QualiMed Innovative Medizinprodukte GmbH

Not yet recruiting

Safety and Efficacy of the QBX Peripheral Balloon Expandable Stent System in Peripheral Artery Disease (PAD) (QBX-RADAR)

Peripheral Arterial Disease

Belgium
Innovative Cellular Therapeutics Inc.

Recruiting

GCC19CART for Patients With Metastatic Colorectal Cancer (CARAPIA-1)

Colorectal Cancer

United States
French Innovative Leukemia Organisation

Recruiting

Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission (LAMSA2020)

Acute Myeloid Leukemia

France
French Innovative Leukemia Organisation

Recruiting

STop and Restart Acalabrutinib In fRail Patients With Previously Untreated Chronic Lymphocytic Leukemia (STAIR)

Untreated Chronic Lymphocytic Leukemia

France
QualiMed Innovative Medizinprodukte GmbH

Recruiting

UNITY-B A Prospective, Multicentric, Single-arm Study to Evaluate the Safety and Efficacy of the UNITY-B Biodegradable Balloon-Expandable Biliary Stent System in Subjects With Biliary Strictures

Bile Duct Diseases | Biliary Obstruction | Bile Duct Stricture

Hong Kong, India, Malaysia
French Innovative Leukemia Organisation

Recruiting

Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A

Chronic Lymphoid Leukemia

France
French Innovative Leukemia Organisation

Completed

JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis

Myelofibrosis

France
Innovative Med Concepts, LLC

Completed

A Study of IMC-1 In Patients With Fibromyalgia

Chronic Pain | Fibromyalgia | Myofascial Pain

United States
QualiMed Innovative Medizinprodukte GmbH

Unknown

Prospective, Post Market Surveillance Q3-registry (POLARIS) (Q3-Registry)

Peripheral Artery Disease

Germany
Innovative Trauma Care Inc.

Withdrawn

Prospective Evaluation of the iTClamp50 to Provide Temporary Wound Closure

Hemorrhage | Bleeding | Wound Closure

Canada
French Innovative Leukemia Organisation

Completed

Efficacy , Safety of Treatment R NIMP for Relapsed Aggressive Lymphomas

Diffuse Large B-Cell Lymphoma

France
Oculus Innovative Sciences, Inc.

Completed

Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults

Pruritus | Atopic Dermatitis

United States
French Innovative Leukemia Organisation

Completed

High-Dose Therapy Treatment in Patients With Follicular Lymphoma

Follicular Lymphoma

France
French Innovative Leukemia Organisation

Completed

Liposomal Anthracyclin in the Treatment of Elderly ALL

Acute Lymphoblastic Leukemia

France
French Innovative Leukemia Organisation

Completed

Treatment of Disseminated High Grade Lymphoma

Lymphoma

France
French Innovative Leukemia Organisation

Completed

Treatment of Localized Low Grade Lymphomas

Lymphoma, Low-Grade

France
French Innovative Leukemia Organisation

Completed

Efficacity of Idelalisib and Obinutuzumab in Patient With Relapsed Refractory Waldenstrom's Macroglobulinemia (RemodelWM3)

Waldenstrom Macroglobulinemia

France
French Innovative Leukemia Organisation

Active, not recruiting

Dexamethasone Added to Intensive Chemotherapy in Older Patients With Acute Myeloid Leukemia (AML) (DEXAML-02)

Acute Myeloid Leukemia

France
French Innovative Leukemia Organisation

Completed

Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg (RUXOPeg)

Myelofibrosis

France
French Innovative Leukemia Organisation

Completed

Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL

B Cell Chronic Lymphocytic Leukemia

France
French Innovative Leukemia Organisation

Terminated

Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma

B-cell Lymphoma

France
French Innovative Leukemia Organisation

Terminated

Treatment of Aggressive Localized Lymphoma

B Cell Lymphoma

France
Oculus Innovative Sciences, Inc.

Completed

Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections

Foot Ulcer, Diabetic

United States
Netherlands Institute for Innovative Ocular Surgery
Amnitrans Eyebank Rotterdam

Completed

Isolated Bowman Layer Graft for Reducing and Stabilizing Advanced Keratoconus

Advanced Keratoconus

Netherlands
Netherlands Institute for Innovative Ocular Surgery
Amnitrans Eyebank Rotterdam

Completed

Descemet Membrane Endothelial Keratoplasty (DMEK) (DMEK)

Corneal Dystrophies, Hereditary

Netherlands
Texas Back Institute
Orthofix Inc.; Innovative Spinal Technologies, Inc.

Completed

A Randomized, Controlled Trial of Treatment for Disc Herniation With Radiating Leg Pain

Radiating Leg Pain | Disc Protrusion

United States

Clinical Trials Sponsored by Innovative Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations